Latest News

Data Show Up to 5-Fold Higher Mortality Risk in Patients With Generalized Pustular Psoriasis
Data Show Up to 5-Fold Higher Mortality Risk in Patients With Generalized Pustular Psoriasis

June 16th 2025

New research reveals that early discontinuation of adjuvant immunotherapy for melanoma does not lead to worse outcomes.

Diagnosing and Managing GPP: Top Insights From the Experts
Diagnosing and Managing GPP: Top Insights From the Experts

June 12th 2025

Targeted TYK2 Blockade for PsO Without JAK1/2/3 Impact
Targeted TYK2 Blockade for PsO Without JAK1/2/3 Impact

June 5th 2025

Arcutis’ Roflumilast Becomes First FDA-Approved Treatment to Receive the NPF’s Seal of Recognition
Arcutis’ Roflumilast Becomes First FDA-Approved Treatment to Receive the NPF’s Seal of Recognition

June 3rd 2025

GLP-1s Emerging as Adjunct Tools in Psoriasis
GLP-1s Emerging as Adjunct Tools in Psoriasis

June 1st 2025

Latest CME Events & Activities

Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis

View More

Revolutionizing Atopic Dermatitis (RAD) Conference 2025

June 6-7, 2025

Register Now!

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

July 26, 2025

Register Now!

Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color

View More

Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach

View More

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

View More

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

View More

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

View More

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

View More

Burst CME: Targeted Therapy for Optimal Psoriasis Management

View More

More News

© 2025 MJH Life Sciences

All rights reserved.